2 main things happened yesterday -start with the n
Post# of 148158
(Total Views: 460)
Posted On: 09/17/2020 7:45:06 AM
2 main things happened yesterday -start with the negative.
- Have to wait A couple Weeks for the CD-12 trial results vs getting instant EAU from FDA but Positive however EAMS still could be approved any day now which is the U.K form of EAU.
Now the positives many doctors were on the call to share their experiences and reinforce that Leronlimab worked in the worst off death bed patients. We saw it worked with Moderate as well but FDA wants the cd-12 data as well. I imagine the biggest factor in that decision is they want Leronlimab to go to the severe population ti save as many lives as possible and not waste any on mild moderate. They left the door open to give to moderate as off label dr’s will be able to decide.
BLA very clear understanding what was needed from FDA so they could resubmit and get PDUFA date.
New study confirms Leronlimab crosses blood brain barrier opening up more future trials potential for billions and billions of new revenue.
Nash hit phase 2 green light will inject first patients in couple
Months NOV. If SP goes down some
Today BUY BUY BUY it’s a early Xmas gift come a couple weeks from now be cashing in BIG TIME!
- Have to wait A couple Weeks for the CD-12 trial results vs getting instant EAU from FDA but Positive however EAMS still could be approved any day now which is the U.K form of EAU.
Now the positives many doctors were on the call to share their experiences and reinforce that Leronlimab worked in the worst off death bed patients. We saw it worked with Moderate as well but FDA wants the cd-12 data as well. I imagine the biggest factor in that decision is they want Leronlimab to go to the severe population ti save as many lives as possible and not waste any on mild moderate. They left the door open to give to moderate as off label dr’s will be able to decide.
BLA very clear understanding what was needed from FDA so they could resubmit and get PDUFA date.
New study confirms Leronlimab crosses blood brain barrier opening up more future trials potential for billions and billions of new revenue.
Nash hit phase 2 green light will inject first patients in couple
Months NOV. If SP goes down some
Today BUY BUY BUY it’s a early Xmas gift come a couple weeks from now be cashing in BIG TIME!
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼